Semaglutide reduces heart attack risk by 20%

irishexaminer.com

A study presented at the European Congress of Obesity revealed that participants taking semaglutide had a 20% lower risk of heart attack, stroke, or death due to cardiovascular disease. The research involved 17,604 adults across 41 countries, showing promising cardiovascular benefits regardless of weight loss. Semaglutide could be a groundbreaking medical breakthrough akin to statins, potentially transforming chronic diseases. Participants on semaglutide lost more weight than those on a placebo.


With a significance score of 4.5, this news ranks in the top 2.8% of today's 27472 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Semaglutide reduces heart attack risk by 20% | News Minimalist